Company Details
Ribocure Pharmaceuticals
Vetenskapens gränd 11, Mölndal, Vastra Gotaland, 431 53, Sweden
Overview
InnoRNA is a Chinese biotech startup. The company closed a $120 million Series B financing. The round was led by CDH Investments and China Renaissance’s Huaxing Healthcare Capital. The article identifies CDH as an alternative asset manager and Huaxing as Huaxing Healthcare Capital. The article does not disclose the company’s products, operating metrics, use of proceeds, or future plans.
- Total raised
- $120M
- Funding rounds
- 1
- Latest round
- Series B
- Latest activity
- Mar 2022
Industries
- Biotechnology
- Pharmaceutical
- Therapeutics
Recent funding
Series B
Mar 2022
$120M